Abiopharma

🔍 McVey J. Kyle (Executive)

Company: FIRST FINANCIAL BANKSHARES INC (FFIN)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Acquired 2,200 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: A | equity_swap_involved: false | shares_owned_after: 28,221.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 536 shares of Common Stock at $29.56 per share (Direct)
  Date: 2026-03-13 | Code: F | equity_swap_involved: false | shares_owned_after: 27,685.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents shares of common stock issued upon the vesting of outstanding performance stock units that were subject to performance criteria other than the issuer's stock price.
• F2: The reporting person elected, in accordance with the Registrant's 2021 Omnibus Stock and Incentive Plan, to exercise his right to have the Registrant withhold 536 shares of the Registrant's common stock to pay income taxes related to vesting of previously granted performance stock units.